 Cyclins CDK4 6 are extensively involved in the proliferation and growth of numerous cancers including breast cancer. The objective of this study is to identify if a new preoperative oral treatment, abemaciclib directed against the CDK 6 compared to no treatment, inhibits tumor growth or induced senescence aging tumor. 